✦ LIBER ✦

High dose ifospamide as a single agent and in combination with cisplatinom in the treatment of advanced/recurrent SQ. cell CA. of head and neck

✍ Scribed by Pai, VR; Parikh, DM; Mazumdar, AT; Rao, RS

Book ID: 122050171
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 157 KB
Volume: 29
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(93)91434-M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiproliferative effects of rapamycin a

Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines

✍ Nasredine Aissat; Christophe Le Tourneau; Aïda Ghoul; Maria Serova; Ivan Bieche; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 518 KB

Treatment of advanced renal cell cancer

Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate

✍ F. Porzsolt; D. Messerer; R. Hautmann; A. Gottwald; H. Sparwasser; K. Stockamp; 📂 Article 📅 1988 🏛 Springer-Verlag 🌐 English ⚖ 602 KB

Combination versus sequential single-age

Combination versus sequential single-agent chemotherapy in the treatment of patients with advanced non-small cell lung cancer

✍ Niell, Harvey B. ;Griffin, John P. ;Hunter, Robert F. ;Meredith, Charlotte A. ;S 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB

We have carried out a randomized phase Ill study in 105 patients with advanced nonsmall cell lung cancer, comparing a fourdrug cisplatin-mitomycin-based combination chemotherapy regimen t o sequential single-agent therapy. The combination chemotherapy regimen consisted of mitomycin C (10 mg/m2), vin

Hyperfractionated radiation in combinati

Hyperfractionated radiation in combination with local hyperthermia in the treatment of advanced squamous cell carcinoma of the head and neck: a phase I–II study

✍ Maurizio Amichetti; Mario Romano; Lucia Busana; Andrea Bolner; Gianni Fellin; Gi 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 395 KB

8550 Clinical experience with Cetuximab

8550 Clinical experience with Cetuximab and Paclitaxel combination in metastatic/recurrent squamous cell cancer carcinoma of the head and neck (SCCHN) – retrospective analysis of a single institution

✍ de Corcuera, I. Diaz; Serrano, C.; Perez, J.; Quispe, I.; Arguis, M.; Muñoz, E.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

An overview of the initial experience wi

An overview of the initial experience with AK-2123 as a hypoxic cell sensitizer with radiation in the treatment of advanced head and neck cancers

✍ Nagraj G. Huilgol; Neela Chatterjee; Ashok R. Mehta 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 376 KB